Internal Reference Number: FOI_8186
Date Request Received: 02/10/2024 00:00:00
Date Request Replied To: 22/10/2024 00:00:00
This response was sent via: By Email
Request Summary: Biologic medicines in gastroenterology
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 1: For the period 1st July 2024 to 30 September 2024: • Adalimumab – Humira 6 • Adalimumab Biosimilar 84 • Etrasimod 0 • Filgotinib 19 • Golimumab 0 • Infliximab – Remicade <5 • Infliximab Biosimilar 87 • Mirikizumab <5 • Ozanimod 0 • Risankizumab 8 • Tofacitinib <5 • Upadacitinib 20 • Ustekinumab (Stelara) 30 • Ustekinumab Biosimilar 62 • Vedolizumab 81 | |
| Question Number 2: If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 2: For the period 1st July 2024 to 30 September 2024: • Adalimumab – Humira <5 • Adalimumab Biosimilar 16 • Etrasimod 0 • Filgotinib 19 • Golimumab 0 • Infliximab – Remicade <5 • Infliximab Biosimilar 33 • Mirikizumab <5 • Ozanimod 0 • Risankizumab 0 • Tofacitinib <5 • Upadacitinib 8 • Ustekinumab (Stelara) 0 • Ustekinumab Biosimilar <5 • Vedolizumab 51 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
